Product image of Monkasta (Montelukast) supplied by GNH India

Monkasta

Active Ingredient:
Montelukast
Origin:
EU

Monkasta (Montelukast)

Montelukast, the active ingredient in Monkasta, is a leukotriene receptor antagonist presented as an oral tablet for oral use. It is indicated for the management of asthma, exercise‑induced bronchoconstriction, and allergic rhinitis in children and adults, helping to reduce airway inflammation and improve breathing.

GNH India supplies Monkasta as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support global distribution. Customers benefit from reliable supply chains and responsive technical support.

Manufacturer / TM Owner

Krka, D.D., Novo Mesto

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Montelukast is a leukotriene receptor antagonist used to treat respiratory allergic conditions.

  • Asthma: improves control of persistent asthma and reduces frequency of exacerbations.
  • Exercise‑induced bronchoconstriction: prevents airway narrowing triggered by physical activity.
  • Allergic rhinitis: alleviates nasal congestion, sneezing and itching associated with seasonal allergies.

How It Works

  • Montelukast selectively blocks the cysteinyl leukotriene receptor CysLT1 on airway smooth‑muscle cells, mast cells, and eosinophils. By antagonizing this receptor, it inhibits the actions of leukotrienes D4, E4 and other cysteinyl leukotrienes, which are mediators that cause bronchoconstriction, mucus secretion, vascular permeability, and inflammatory cell recruitment. This results in reduced airway inflammation and improved airflow. The blockade is dose‑dependent and persists for 24 hours, allowing once‑daily dosing.

Side Effects

Montelukast is generally well tolerated, but some patients may experience adverse reactions.

Common Side Effects

  • Headache: mild to moderate headache.
  • Upper respiratory tract infection: symptoms such as sore throat or nasal congestion.
  • Abdominal pain: mild stomach discomfort.
  • Cough: occasional dry cough.

Serious or Rare Side Effects

  • Allergic reactions: rash, itching, swelling, or anaphylaxis.
  • Neuropsychiatric events: agitation, depression, or suicidal thoughts.
  • Hepatic dysfunction: elevated liver enzymes or hepatitis.

Precautions & Warnings

When prescribing Montelukast, clinicians should consider several precautionary measures to ensure safe use.

  • Assess asthma control: confirm that the patient’s asthma is not uncontrolled before initiating therapy.
  • Monitor for neuropsychiatric symptoms: observe for mood changes, depression, or suicidal ideation.
  • Review concomitant medications: evaluate potential drug interactions, especially with CYP450 modulators.
  • Use in pediatric patients: follow age‑specific dosing recommendations and monitor growth.
  • Pregnancy and lactation: weigh potential benefits against unknown risks; consult current guidelines.
  • Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Montelukast may interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

  • Strong CYP3A4 inducers: drugs such as rifampin or carbamazepine may reduce Montelukast plasma levels.
  • Phenobarbital: may decrease therapeutic effect.

Moderate Interactions (Monitor Closely)

  • Antifungal agents (ketoconazole, itraconazole): may increase Montelukast concentrations.
  • Warfarin: potential for altered anticoagulant effect; monitor INR.
  • Beta‑agonists: additive bronchodilation effect; monitor for excessive bronchodilation.

Frequently Asked Questions

Monkasta contains the active ingredient Montelukast and is prescribed to manage chronic asthma, prevent exercise‑induced bronchoconstriction, and relieve symptoms of allergic rhinitis such as nasal congestion, sneezing and itching.

Montelukast blocks the cysteinyl leukotriene receptor CysLT1, preventing leukotrienes D4, E4 and related molecules from triggering bronchoconstriction, mucus production and inflammation in the airways, thereby improving breathing and reducing allergic symptoms.

The appropriate dose of Monkasta is determined by the prescribing healthcare professional based on the patient’s age, weight, severity of disease and any other relevant clinical factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for Montelukast in pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against possible risks and consider alternative therapies when appropriate. Women who are pregnant, planning pregnancy, or breastfeeding should discuss use with their doctor.

To request Monkasta, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Monkasta (Montelukast) belongs to the leukotriene receptor antagonist class, offering an oral alternative to inhaled corticosteroids or long‑acting beta‑agonists. It is particularly useful for patients who need additional control of allergic components or who cannot use inhalers effectively, though it is often used in combination with other controller medications.

Monkasta should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture, heat and direct sunlight to maintain stability and potency.

Monkasta is taken orally, usually as a tablet swallowed whole with water. It is commonly prescribed once daily, but the exact timing and whether it should be taken with food are determined by the prescribing clinician.

Serious adverse events, although rare, include severe allergic reactions such as rash, swelling or anaphylaxis, neuropsychiatric effects like depression, agitation or suicidal thoughts, and liver injury indicated by elevated enzymes or hepatitis. Patients should seek immediate medical attention if any of these occur.

Monkasta is contraindicated in individuals with known hypersensitivity to Montelukast or any component of the formulation. Caution is advised for patients with a history of severe neuropsychiatric disorders, liver disease, or those taking strong CYP3A4 inducers that may reduce its effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Montelukast

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT